Nanocell targeting using engineered bispecific antibodies

Author:

Taylor Karin1,Howard Christopher B1,Jones Martina L1,Sedliarou Ilya2,MacDiarmid Jennifer2,Brahmbhatt Himanshu2,Munro Trent P1,Mahler Stephen M13

Affiliation:

1. Australian Institute for Bioengineering and Nanotechnology (AIBN); University of Queensland, St Lucia; Queensland, Australia

2. EnGeneIC Ltd; New South Wales, Australia

3. School of Chemical Engineering; University of Queensland, St Lucia; Queensland, Australia

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review;Journal of Controlled Release;2023-07

2. Nucleic Acid Therapeutics in Cancer Biology;Nucleic Acid Biology and its Application in Human Diseases;2023

3. Effective flow-through polishing strategies for knob-into-hole bispecific antibodies;Bioresources and Bioprocessing;2022-09-14

4. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics;WIREs Nanomedicine and Nanobiotechnology;2022-08-18

5. Mineralized vectors for gene therapy;Acta Biomaterialia;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3